Tempur Sealy, a leading bedding manufacturer, has announced plans to introduce surface-guard technology, an antimicrobial and antiviral technology expected to be included on select Sealy products beginning in early 2021. The company is pursuing antiviral-efficacy claims approval from the US Food & Drug Administration and Environmental Protection Agency.
The EPA-registered antimicrobial technology kills 99 per cent of bacteria on mattress surfaces and, in testing, has also shown to be at least 99 per cent effective against killing viruses (including human coronavirus) on textiles within five minutes.
The technology will add enhanced mattress protection across the Sealy Posturepedic and Sealy Posturepedic Plus mattress collections and will build on the pioneering antimicrobial and anti-allergen treatment developed and first used by Tempur Sealy over ten years ago. The addition of this antimicrobial and antiviral treatment to Sealy mattress covers will build on the company’s longstanding commitment to delivering high-quality mattresses that sleepers can count on, night after night, the company said in a media statement.
In keeping with this commitment, Tempur Sealy also plans to incorporate Surface-Guard Technology into the Tempur-Pedic and Stearns and Foster lines in 2021, in order to make this exceptional level of antimicrobial and antiviral mattress protection available to even more consumers.
“Tempur Sealy is proud to announce our plans to incorporate Surface-Guard Technology antimicrobial and antiviral treatment on Sealy, Tempur-Pedic and Stearns & Foster products as soon as early next year. Making Surface-Guard Technology available across our industry-leading portfolio of brands represents the latest in a long line of innovations from Tempur Sealy. Our planned introduction of this cutting-edge technology will help keep our mattresses clean and safe, and will be yet another reason for consumers to turn to Tempur Sealy products for their best night’s sleep,” Scott Thompson, Tempur Sealy chairman, CEO, and president said.
